dr. A.D. (Alain) Dekker

Researcher - teacher

dr. A.D. (Alain) Dekker
E-mail:
a.d.dekker umcg.nl

Research

  1. 2019
  2. Reeves, R. H., Delabar, J., Potier, M-C., Bhattacharyya, A., Head, E., Lemere, C., ... Busciglio, J. (2019). Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society. Molecular Syndromology, 9(6), 279-286. https://doi.org/10.1159/000494231
  3. 2018
  4. Down Syndrome and Other Genetic Developmental Disorders ECNP Network, Faundez, V., De Toma, I., Bardoni, B., Bartesaghi, R., Nizetic, D., ... Potier, M-C. (2018). Translating molecular advances in Down syndrome and Fragile X syndrome into therapies. European Neuropsychopharmacology, 28(6), 675-690. https://doi.org/10.1016/j.euroneuro.2018.03.006
  5. 2017
  6. Dekker, A. D., De Deyn, P., & Rots, M. G. (2017). Chapter 9: Epigenetics and Down Syndrome. In D. H. Yasui, J. Peedicayil, & D. R. Grayson (Eds.), Neuropsychiatric Disorders and Epigenetics (pp. 163-178). (Translational Epigenetics Series). London: Academic Press - Elsevier.
  7. Dekker, A. D. (2017). Down & Alzheimer: Behavioural biomarkers of a forced marriage. [Groningen]: Rijksuniversiteit Groningen.
  8. 2016
  9. Dekker, A., De Deyn, P., & Rots, M. (2016). Epigenetic therapies may alleviate cognitive deficits in Down syndrome by downregulating overexpressed chromosome 21 gene products. In D. Yasui, J. Peedicayil, & D. Grayson (Eds.), Neuropsychiatric Disorders and Epigenetics Elsevier.
  10. Delabar, J. M., Allinquant, B., Bianchi, D., Blumenthal, T., Dekker, A., Edgin, J., ... Busciglio, J. (2016). Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society. Molecular Syndromology, 7(5), 251-261. https://doi.org/10.1159/000449049
  11. 2015
  12. 2014
  13. 2013

ID: 13760237